Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation (AF) (Code-AF Trial)

Conditions

Atrial Fibrillation

Keywords

Atrial fibrillation, anti arrhythmic drug, NOAC, warfarin, coumadin

Brief summary

This study is prospective Cohort study which was performed in multicenter (General Hospital) in Korea. Inclusion criteria is all patients with atrial fibrillation who visit hospital. The purpose is to analyze complication, composite outcome (all cause mortality, hospitalization, the incidence of stroke, heart failure and cardiovascular event (MACE)) according to the 1) the use of anti-arrhythmic drugs (AADs), 2) use of medication for rate control (beta blocker, calcium channel blocker and digoxin) and 3) use of anticoagulation agents (warfarin, coumadin, an NOAC)

Hanjin Park, Hee Tae Yu, Tae‐Hoon Kim, Junbeom Park, Jin‐Kyu Park et al. (13 authors)

Yonsei Medical Journal2022-12-1914 citations

10.3349/ymj.2022.0455

Clinical Outcomes of Rhythm Control Strategies for Asymptomatic Atrial Fibrillation According to the Quality‐of‐Life Score: The CODE‐AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) Registry

Ju Youn Kim, Hyoung‐Seob Park, Hyung Wook Park, Eue‐Keun Choi, Jin‐Kyu Park et al. (10 authors)

Journal of the American Heart Association2022-09-0818 citations

10.1161/jaha.122.025956

Association of Gender With Clinical Outcomes in a Contemporary Cohort of Patients With Atrial Fibrillation Receiving Oral Anticoagulants

Minjeong Kim, Jun Kim, Jin‐Bae Kim, Junbeom Park, Jin‐Kyu Park et al. (11 authors)

Korean Circulation Journal2022-01-017 citations

10.4070/kcj.2021.0399

Stroke and Systemic Thromboembolism according to CHA<sub>2</sub>DS<sub>2</sub>-VASc Score in Contemporary Korean Patients with Atrial Fibrillation

Kyung Bae Lee, Tae‐Hoon Kim, Junbeom Park, Jin‐Kyu Park, Ki‐Woon Kang et al. (12 authors)

Yonsei Medical Journal2022-01-014 citations

10.3349/ymj.2022.63.4.317

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* patients with atrial fibrillation * patients with age more than 19 * patients who agree with study inclusion

Exclusion criteria

* patients who do not agree with study inclusion * patients with age less than 19 * Pregnancy, Breastfeeding

Design outcomes

Primary

Measure	Time frame
all cause mortality	3 years
number of hospitalization by heart failure	3 years
number of recurrent stroke	3 years
number of cardiovascular events	3 years

Countries

South Korea

Outcome results